<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><description>让药物创造变得容易！我们致力于成为中国健康产业的传播者、服务者、推动者。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 07 Apr 2021 19:21:01 +0800</pubDate><image><url>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</url><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>当Me-too变成We-too，中国创新药之路该怎么走？</title><link>https://mp.weixin.qq.com/s/mMWhL8oM-JzYtNIItHINpA</link><description></description><content:encoded><![CDATA[当Me-too变成We-too，中国创新药之路该怎么走？]]></content:encoded><pubDate>Wed, 07 Apr 2021 17:31:18 +0800</pubDate></item><item><title>全球顶级药企“创新实验室Top10”出炉：拜耳、辉瑞、诺华…</title><link>https://mp.weixin.qq.com/s/6D5dlzsyS5S2FlFfCTrv8A</link><description></description><content:encoded><![CDATA[全球顶级药企“创新实验室Top10”出炉：拜耳、辉瑞、诺华…]]></content:encoded><pubDate>Wed, 07 Apr 2021 17:31:18 +0800</pubDate></item><item><title>57个大品种集采，265家药企报价</title><link>https://mp.weixin.qq.com/s/T8QuW7GLPCZ8m6HTvdXDgg</link><description></description><content:encoded><![CDATA[57个大品种集采，265家药企报价]]></content:encoded><pubDate>Wed, 07 Apr 2021 17:31:18 +0800</pubDate></item><item><title>头孢呋辛、阿卡米星修订说明书，或影响70亿市场</title><link>https://mp.weixin.qq.com/s/bvCvR0CQeFwp7CZqrEiGgg</link><description></description><content:encoded><![CDATA[头孢呋辛、阿卡米星修订说明书，或影响70亿市场]]></content:encoded><pubDate>Wed, 07 Apr 2021 17:31:18 +0800</pubDate></item><item><title>两次资产重组，转型CRO业务，百花村仍难逃困境</title><link>https://mp.weixin.qq.com/s/rr2HznQmWqHxo0QlqZ3Prw</link><description></description><content:encoded><![CDATA[两次资产重组，转型CRO业务，百花村仍难逃困境]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:42:42 +0800</pubDate></item><item><title>中国企业接棒医用敷料生产，2030年市场规模有望突破200亿！</title><link>https://mp.weixin.qq.com/s/dfMiDIgWSLsavT9sF-OMTA</link><description></description><content:encoded><![CDATA[中国企业接棒医用敷料生产，2030年市场规模有望突破200亿！]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:42:42 +0800</pubDate></item><item><title>复星医药的2020：疫苗一支没来得及卖，疫苗股先挣了5亿</title><link>https://mp.weixin.qq.com/s/fyuwiA3UzvyqPvrhwDu26g</link><description></description><content:encoded><![CDATA[复星医药的2020：疫苗一支没来得及卖，疫苗股先挣了5亿]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:42:42 +0800</pubDate></item><item><title>2021才过去3个月，多家知名药企高管已离职</title><link>https://mp.weixin.qq.com/s/0A7O1UmagxymPnrjhGACQg</link><description></description><content:encoded><![CDATA[2021才过去3个月，多家知名药企高管已离职]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:42:42 +0800</pubDate></item><item><title>（4月21-23日北京）稽查、现场检查实例讲解专题研修班的通知</title><link>https://mp.weixin.qq.com/s/cwcWKiQmCE8VRaaQSRoJmQ</link><description></description><content:encoded><![CDATA[（4月21-23日北京）稽查、现场检查实例讲解专题研修班的通知]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:42:42 +0800</pubDate></item><item><title>市值260亿！他27岁弃医从商，创心脑血管龙头药企！</title><link>https://mp.weixin.qq.com/s/a-6eANswUWTEWU_Y3oPOuA</link><description></description><content:encoded><![CDATA[市值260亿！他27岁弃医从商，创心脑血管龙头药企！]]></content:encoded><pubDate>Mon, 05 Apr 2021 08:30:54 +0800</pubDate></item><item><title>【药咖君】两款License in新药获批上市！君实PD-1第3项适应症即将获批，基石药业、再鼎医药…</title><link>https://mp.weixin.qq.com/s/dxw43u3xI86oXwgIZzLvTA</link><description></description><content:encoded><![CDATA[【药咖君】两款License in新药获批上市！君实PD-1第3项适应症即将获批，基石药业、再鼎医药…]]></content:encoded><pubDate>Sun, 04 Apr 2021 10:06:07 +0800</pubDate></item><item><title>CDE药审分析，48个化药1类品种，59个一致性评价获受理，恒瑞、以岭药业…</title><link>https://mp.weixin.qq.com/s/NdKOkgJjB7_99wznTbxNZg</link><description></description><content:encoded><![CDATA[CDE药审分析，48个化药1类品种，59个一致性评价获受理，恒瑞、以岭药业…]]></content:encoded><pubDate>Fri, 02 Apr 2021 18:01:51 +0800</pubDate></item><item><title>52个品种过评，多款重磅注射剂!四川药企厉害了，科伦、成都倍特…</title><link>https://mp.weixin.qq.com/s/sIkgtPXijHKSCxUwOVbB-g</link><description></description><content:encoded><![CDATA[52个品种过评，多款重磅注射剂!四川药企厉害了，科伦、成都倍特…]]></content:encoded><pubDate>Fri, 02 Apr 2021 18:01:51 +0800</pubDate></item><item><title>市场萎缩483亿！集采带来行业内卷化，药企还活得下去吗？</title><link>https://mp.weixin.qq.com/s/CKtQnj_k2STifOi6_Ao18A</link><description></description><content:encoded><![CDATA[市场萎缩483亿！集采带来行业内卷化，药企还活得下去吗？]]></content:encoded><pubDate>Fri, 02 Apr 2021 11:39:35 +0800</pubDate></item><item><title>威凯尔医药第二代TRK抑制剂VC004项目完成关键剂量组爬坡试验</title><link>https://mp.weixin.qq.com/s/hCH9NWRQeEbr2tIE6VQn7A</link><description></description><content:encoded><![CDATA[威凯尔医药第二代TRK抑制剂VC004项目完成关键剂量组爬坡试验]]></content:encoded><pubDate>Fri, 02 Apr 2021 11:39:35 +0800</pubDate></item><item><title>一文盘点肿瘤免疫治疗不良反应与新靶点！</title><link>https://mp.weixin.qq.com/s/gxpP-j_HUUGoPQjCBbGFlw</link><description></description><content:encoded><![CDATA[一文盘点肿瘤免疫治疗不良反应与新靶点！]]></content:encoded><pubDate>Fri, 02 Apr 2021 11:39:35 +0800</pubDate></item><item><title>最新！31家药企高管离职（附名单）</title><link>https://mp.weixin.qq.com/s/foy11Te1b1BjOBb1kP-dKQ</link><description></description><content:encoded><![CDATA[最新！31家药企高管离职（附名单）]]></content:encoded><pubDate>Fri, 02 Apr 2021 11:39:35 +0800</pubDate></item><item><title>制药企业营收Top榜出炉！强生夺冠，辉瑞下跌至第八，安斯泰来新上榜...</title><link>https://mp.weixin.qq.com/s/N6bHuA6bVytGg1iOPLtXJw</link><description></description><content:encoded><![CDATA[制药企业营收Top榜出炉！强生夺冠，辉瑞下跌至第八，安斯泰来新上榜...]]></content:encoded><pubDate>Thu, 01 Apr 2021 18:09:17 +0800</pubDate></item><item><title>ADC药物崭露头角？齐鲁、石药、恒瑞...</title><link>https://mp.weixin.qq.com/s/zCAS7KplZjjSOg-YCE738w</link><description></description><content:encoded><![CDATA[ADC药物崭露头角？齐鲁、石药、恒瑞...]]></content:encoded><pubDate>Thu, 01 Apr 2021 18:09:17 +0800</pubDate></item><item><title>用量大都会进集采吗？漏洞已补上：不参与、串标、风险防范</title><link>https://mp.weixin.qq.com/s/vejRAh1YdVqJL66kM0MekQ</link><description></description><content:encoded><![CDATA[用量大都会进集采吗？漏洞已补上：不参与、串标、风险防范]]></content:encoded><pubDate>Thu, 01 Apr 2021 18:09:17 +0800</pubDate></item></channel></rss>